‘If cough persists...’: Govt discourages steroid use for Covid treatment | Latest News India - Hindustan Times
close_game
close_game

‘If cough persists...’: Govt discourages steroid use for Covid treatment

By | Written by Kunal Gaurav
Jan 18, 2022 11:34 AM IST

The government-recommended treatments do not include medicines like ivermectin, favipiravir and Doxycycline.

There is no evidence of benefit from injectable steroids in coronavirus disease (Covid-19) patients who do not require oxygen supplementation or in continuation, after discharge, the government has said in its revised guidelines. The clinical guidance jointly issued by AIIMS, the Indian Council of Medical Research (ICMR) and Covid-19 National Task Force and Joint Monitoring Group warned that anti-inflammatory therapy can lead to a risk of secondary infection like invasive mucormycosis, or ‘black fungus’.

The government warned that anti-inflammatory therapy can lead to a risk of secondary infection like invasive mucormycosis, or ‘black fungus’.(PTI)
The government warned that anti-inflammatory therapy can lead to a risk of secondary infection like invasive mucormycosis, or ‘black fungus’.(PTI)

"There is no evidence for benefit for injectable steroids in those not requiring oxygen supplementation, or on continuation after discharge anti-inflammatory or immunomodulatory therapy (such as steroids) can have a risk of secondary infection such as invasive mucormycosis when used too early, at higher doses or for longer than required," the guidelines stated.

Hindustan Times - your fastest source for breaking news! Read now.

Under the anti-inflammatory or immunomodulatory therapy, the guidelines say, “Injection Methylprednisolone 0.5 to 1 mg/kg in two divided doses or equivalent dose of dexamethasone can be given usually for a duration of 5 to 10 days” in Covid-19 patients. The medicine can be administered orally if the condition of the patient is stable and/or improving.

Govt warns against overuse, misuse of Covid medicines

Adult Covid-19 patients have been divided into three categories of mild, moderate and severe disease based on upper respiratory tract symptoms and breathlessness. The government-recommended treatments do not include medicines like ivermectin, favipiravir and Doxycycline. Antivirals like Molnupiravir and monoclonal antibodies are also not included in the guidelines.

The government has advised people to investigate for tuberculosis and other conditions if cough persists for more than 2-3 weeks after testing positive for Covid-19.

According to the guidelines, people aged 60 and above with cardiovascular disease, hypertension, and CAD Diabetes mellitus and other immunocompromised states (such as HIV), active tuberculosis, chronic lung/kidney/liver disease, cerebrovascular disease, and obesity are at high risk for severe disease or mortality.

Unveiling Elections 2024: The Big Picture', a fresh segment in HT's talk show 'The Interview with Kumkum Chadha', where leaders across the political spectrum discuss the upcoming general elections. Watch now!

Get Current Updates on India News, Election 2024, Arvind Kejriwal News Live, Bihar Board 10th Result 2024 Live along with Latest News and Top Headlines from India and around the world.
SHARE THIS ARTICLE ON
Share this article
SHARE
Story Saved
Live Score
OPEN APP
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Thursday, March 28, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On